Rights and permissions
About this article
Cite this article
Infliximab dose escalation not uncommon during first year in RA. Inpharma Wkly. 1520, 6 (2006). https://doi.org/10.2165/00128413-200615200-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615200-00013